Current Obesity Reports

Papers
(The H4-Index of Current Obesity Reports is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Sex/Gender Differences in Obesity Prevalence, Comorbidities, and Treatment191
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?163
Vitamin D and Obesity: Current Evidence and Controversies116
Adolescent and Childhood Obesity and Excess Morbidity and Mortality in Young Adulthood—a Systematic Review93
Mediterranean Diet and Obesity-related Disorders: What is the Evidence?77
COVID-19 Self-quarantine and Weight Gain Risk Factors in Adults72
Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence58
Time-Restricted Eating, Intermittent Fasting, and Fasting-Mimicking Diets in Weight Loss57
Obesity Stigma: Causes, Consequences, and Potential Solutions55
Ultra-processed Foods, Weight Gain, and Co-morbidity Risk51
Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives49
Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives49
Gender Differences in Obesity-Related Cancers49
Update on the Obesity Epidemic: After the Sudden Rise, Is the Upward Trajectory Beginning to Flatten?47
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care47
Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease42
Batokines: Mediators of Inter-Tissue Communication (a Mini-Review)40
The COVID-19, Obesity, and Food Insecurity Syndemic37
Developing Integrated Clinical Pathways for the Management of Clinically Severe Adult Obesity: a Critique of NHS England Policy35
The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities31
Obesity Paradox: Fact or Fiction?31
The Most Undertreated Chronic Disease: Addressing Obesity in Primary Care Settings30
Use of Weight Loss Medications in Patients after Bariatric Surgery30
Weight Bias During the COVID-19 Pandemic28
Social Isolation and Loneliness During the COVID-19 Pandemic: Impact on Weight26
The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease26
0.028908014297485